Company Profile
Compass Pathway
3.0
Avg Sentiment
Sentiment Over Time
Analysis Timeline
3.0
Score
2026-02-18
"Biotech firm's stock gained 40% after presenting preliminary study data for a psilocybin-based medication, reflecting positive investor reaction to trial progress."